Key stats
About CHINA ASSET MANAGEMENT CO CAMC CSI BIOTECH
Home page
Inception date
Mar 4, 2021
Structure
Open-Ended Fund
Replication method
Synthetic
Dividend treatment
Distributes
Income tax type
Capital Gains
Primary advisor
China Asset Management Co., Ltd.
ISIN
CNE100004F18
Closely track underlying index,Tightly track the target and minimize the deviation
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks98.57%
Health Technology93.48%
Commercial Services1.91%
Transportation1.14%
Producer Manufacturing0.80%
Health Services0.68%
Distribution Services0.56%
Bonds, Cash & Other1.43%
Cash1.43%
Stock breakdown by region
Asia97.78%
North America2.22%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history